Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms
about
The therapeutic profile of rolipram, PDE target and mechanism of action as a neuroprotectant following spinal cord injuryCyclic nucleotide specific phosphodiesterases of Leishmania major.Mechanisms for the modulation of dopamine d(1) receptor signaling in striatal neuronsThe Chlorella variabilis NC64A genome reveals adaptation to photosymbiosis, coevolution with viruses, and cryptic sexCyclic AMP-dependent transcriptional up-regulation of phosphodiesterase 4D5 in human airway smooth muscle cells. Identification and characterization of a novel PDE4D5 promoterCharacterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D geneIdentification and tissue-specific expression of PDE7 phosphodiesterase splice variantsImmunohistochemical localization of phosphodiesterase 2A in multiple mammalian speciesReceptor-mediated stimulation of lipid signalling pathways in CHO cells elicits the rapid transient induction of the PDE1B isoform of Ca2+/calmodulin-stimulated cAMP phosphodiesteraseMolecular cloning and transient expression in COS7 cells of a novel human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579.mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling moduleMolecular cloning and subcellular distribution of the novel PDE4B4 cAMP-specific phosphodiesterase isoformPer-Arnt-Sim domain-dependent association of cAMP-phosphodiesterase 8A1 with IkappaB proteinscGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytesSynthesis of quinoline derivatives: discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer's diseaseT cell activation up-regulates cyclic nucleotide phosphodiesterases 8A1 and 7A3Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex.NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potentialThe 39-kDa poly(ADP-ribose) glycohydrolase ARH3 hydrolyzes O-acetyl-ADP-ribose, a product of the Sir2 family of acetyl-histone deacetylasesPhosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment responseMolecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11ACloning and characterization of two splice variants of human phosphodiesterase 11APotential role of phosphodiesterase 7 in human T cell function: comparative effects of two phosphodiesterase inhibitorsPivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replicationEMD273316 & EMD95833, type 4 phosphodiesterase inhibitors, stimulate fibroblastic-colony formation by bone marrow cells via direct inhibition of PDE4 and the induction of endogenous prostaglandin synthesisDelineation of RAID1, the RACK1 interaction domain located within the unique N-terminal region of the cAMP-specific phosphodiesterase, PDE4D5.Association between a variation in the phosphodiesterase 4D gene and bone mineral densityThe effect of selective phosphodiesterase inhibitors, alone and in combination, on a murine model of allergic asthmaOral sildenafil (Viagra) in male erectile dysfunction: use, efficacy and safety profile in an unselected cohort presenting to a British district general hospitalInhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migrationLong-term therapy of interferon-alpha induced pulmonary arterial hypertension with different PDE-5 inhibitors: a case report.Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors.The Extracellular Calcium-Sensing Receptor in the Intestine: Evidence for Regulation of Colonic Absorption, Secretion, Motility, and ImmunityThe ever unfolding story of cAMP signaling in trypanosomatids: vive la difference!The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fractionPathophysiology of visual disorders induced by phosphodiesterase inhibitors in the treatment of erectile dysfunctionCloning and characterization of PDE7B, a cAMP-specific phosphodiesteraseExpression and mutagenesis of the catalytic domain of cGMP-inhibited phosphodiesterase (PDE3) cloned from human plateletsTAPAS-1, a novel microdomain within the unique N-terminal region of the PDE4A1 cAMP-specific phosphodiesterase that allows rapid, Ca2+-triggered membrane association with selectivity for interaction with phosphatidic acid
P2860
Q21089854-96DEB581-8F72-4550-93F2-EE18DF31EEC0Q21093362-0172CA23-6E9D-4E0A-927A-3FE34B753E88Q21131062-DCF89D81-555C-420F-94F8-65DCC3A121AEQ22065724-9A0D21EC-2EDD-43B5-ADEB-BA24FEE56D32Q24301633-90997F0E-5EF5-44C7-9E57-B9D72AE71695Q24308220-4D7FAB4C-C267-448C-A48E-5B3BD8D75A3FQ24323729-A138F70B-5701-42C3-9EA4-C2D2EB1D8EE2Q24337499-25E9A237-960F-4251-BAF0-E246F1DA1A5FQ24530028-ED67927D-0F92-45EA-8ACF-66DF17DC17E9Q24530596-A5D7F8F2-2BB6-418D-BFFA-68256EBEE46AQ24533566-40866481-DFE5-4501-A949-57601FEEBA85Q24535019-C408EF84-05D2-4BA2-9A87-3134C6EA2E5DQ24535564-8213078C-E3EC-4FED-A2D7-D1DDFC860D83Q24558611-86982411-49AE-4FD1-8ECC-9EEA7265BC9FQ24561615-A93C2A73-B61B-45D1-A884-AFB82618AD58Q24615907-E4E422BD-311C-4D45-9056-E7F2B4C157A9Q24627662-D00DF6D5-786D-4553-8F72-0B5C2A3E82D3Q24633622-824FA26B-2049-4156-B334-821CF5C76B9EQ24656131-DF7354A1-4FEA-48E9-9F2F-EB2C32374DF1Q24672688-9CF15410-F36E-4538-97EB-BE859D2320B6Q24674385-71113EB7-E26D-4F28-8327-5B44D276DBB2Q24676441-ADA18DD6-9170-45A8-8AE2-7E65409613E8Q24676977-1D89143E-5976-4BA0-A86F-5816BBE68698Q24681386-8A78362B-105B-4FAA-B620-7D036DD848CEQ24684750-D62BE847-0BA3-4750-BE6B-AD7671ABD763Q24801730-A6CB5F09-8143-4C4A-A8E4-B5085E761AB4Q24801846-64C79518-6A04-4275-BC3E-652D0CB98955Q24802926-3E707E13-E747-4FCC-8A33-43775FE57196Q24804029-5789B412-AA23-4D6D-9079-8204EBADA1D2Q24807404-AAB5F42B-F3D6-4A4E-B3F0-3267665113EFQ24812224-BAB508A2-EE10-41DD-907A-FB911CDCCBACQ24813821-99EE96DD-6D11-441F-B405-47171CF04A35Q24815216-773169F7-F6D9-466F-92BD-CD9BB652A65EQ26741598-B5AE6C3E-9AD0-4AD3-AB1F-EAA6C76714E1Q26781588-96B55E6F-1194-48C6-B08A-F584F5DCDA1DQ27024279-4C94AA2F-3916-4A2D-805D-B34A99CAB373Q28067059-2DBDDA43-0EB1-4144-81FD-3B1F0B1982C2Q28118391-43F83ABE-632F-4FD9-8EE5-6CCBBBFDEE7EQ28118508-03BF208E-793F-4048-B63A-A4D76FE22E26Q28216705-FCF6F738-7F3B-4F55-8798-B226AE709D93
P2860
Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms
description
1995 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1995
@ast
im Oktober 1995 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: October 1995)
@en
wetenschappelijk artikel (gepubliceerd in 1995-10)
@nl
наукова стаття, опублікована в жовтні 1995
@uk
مقالة علمية (نشرت في أكتوبر 1995)
@ar
name
Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms
@ast
Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms
@en
type
label
Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms
@ast
Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms
@en
prefLabel
Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms
@ast
Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms
@en
P3181
P1476
Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms
@en
P2093
P304
P3181
P356
10.1152/PHYSREV.1995.75.4.725
P407
P577
1995-10-01T00:00:00Z